Alkermes (ALKS) Other Operating Expenses (2010 - 2026)

Alkermes' (ALKS) quarterly Other Operating Expenses came in at $228.8 million in Q1 2026, up 32.93% year-on-year from $172.1 million in Q1 2025, and up 129.06% on a QoQ basis from -$787.3 million in Q4 2025.

Alkermes (ALKS) Other Operating Expenses (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Other Operating Expenses data on file, last reported at $228.8 million in Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 32.93% year-over-year to $228.8 million in Q1 2026; TTM through Mar 2026 was -$633.6 million, a 2162.91% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 billion, down 2667.28% from the prior year.
  • Other Operating Expenses for Q1 2026 stood at $228.8 million, up from -$787.3 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for ALKS reached as high as $569.3 million in Q4 2023 and fell as low as -$787.3 million in Q4 2025.
  • Historically, Other Operating Expenses has averaged $2.4 million across 5 years, with a median of $64.2 million in 2023.
  • Across the five-year window, Other Operating Expenses slumped 1591.94% in 2022 and soared 8192.76% in 2023, its largest moves.
  • Year by year, Other Operating Expenses stood at -$3.6 million in 2022, then surged by 16122.4% to $569.3 million in 2023, then tumbled by 157.25% to -$325.9 million in 2024, then sank by 141.56% to -$787.3 million in 2025, then surged by 129.06% to $228.8 million in 2026.
  • Per Business Quant data, the three most recent Other Operating Expenses figures were $228.8 million in Q1 2026, -$787.3 million in Q4 2025, and $167.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Alkermes 8.78 Bn 8.27 Bn 331.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 228.82 Mn
Dec 31, 2025 -787.26 Mn
Sep 30, 2025 167.22 Mn
Jun 30, 2025 -242.34 Mn
Mar 31, 2025 172.13 Mn
Dec 31, 2024 -325.91 Mn
Sep 30, 2024 123.01 Mn
Jun 30, 2024 61.49 Mn
Mar 31, 2024 -116.32 Mn
Dec 31, 2023 569.28 Mn
Sep 30, 2023 70.49 Mn
Jun 30, 2023 72.15 Mn
Mar 31, 2023 66.96 Mn
Sep 30, 2022 -3.55 Mn
Jun 30, 2022 870,000.00
Mar 31, 2022 -19.07 Mn
Dec 31, 2021 -750,000.00
Sep 30, 2021 -5.20 Mn
Jun 30, 2021 3.24 Mn
Mar 31, 2021 1.28 Mn